Hepatitis C Virus Phylogenetic Clustering Is Associated with the Social-Injecting Network in a Cohort of People Who Inject Drugs

被引:60
|
作者
Sacks-Davis, Rachel [1 ,2 ,3 ]
Daraganova, Galina
Aitken, Campbell [1 ,2 ,3 ]
Higgs, Peter [1 ,2 ,3 ]
Tracy, Lilly [5 ]
Bowden, Scott [5 ]
Jenkinson, Rebecca [1 ,3 ]
Rolls, David
Pattison, Philippa
Robins, Garry
Grebely, Jason [4 ]
Barry, Alyssa [6 ,7 ]
Hellard, Margaret [1 ,2 ,3 ]
机构
[1] Burnet Inst, Ctr Populat Hlth, Melbourne, Vic, Australia
[2] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia
[3] Burnet Inst, Ctr Res Excellence Injecting Drug Use, Melbourne, Vic, Australia
[4] Univ New S Wales, Kirby Inst Infect & Immun Soc, Darlinghurst, NSW, Australia
[5] Victorian Infect Dis Reference Lab, Melbourne, Vic, Australia
[6] Walter & Eliza Hall Inst Med Res, Div Infect & Immun, Parkville, Vic, Australia
[7] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia
来源
PLOS ONE | 2012年 / 7卷 / 10期
基金
澳大利亚研究理事会; 英国医学研究理事会;
关键词
MOLECULAR EPIDEMIOLOGY; GLOBAL EPIDEMIOLOGY; USERS; INCARCERATION; HIV; TRANSMISSION; INFECTION; GENOTYPES;
D O I
10.1371/journal.pone.0047335
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
It is hypothesized that social networks facilitate transmission of the hepatitis C virus (HCV). We tested for association between HCV phylogeny and reported injecting relationships using longitudinal data from a social network design study. People who inject drugs were recruited from street drug markets in Melbourne, Australia. Interviews and blood tests took place three monthly (during 2005-2008), with participants asked to nominate up to five injecting partners at each interview. The HCV core region of individual isolates was then sequenced and phylogenetic trees were constructed. Genetic clusters were identified using bootstrapping (cut-off: 70%). An adjusted Jaccard similarity coefficient was used to measure the association between the reported injecting relationships and relationships defined by clustering in the phylogenetic analysis (statistical significance assessed using the quadratic assignment procedure). 402 participants consented to participate; 244 HCV infections were observed in 238 individuals. 26 genetic clusters were identified, with 2-7 infections per cluster. Newly acquired infection (AOR = 2.03, 95% CI: 1.04-3.96, p = 0.037, and HCV genotype 3 (vs. genotype 1, AOR = 2.72, 95% CI: 1.48-4.99) were independent predictors of being in a cluster. 54% of participants whose infections were part of a cluster in the phylogenetic analysis reported injecting with at least one other participant in that cluster during the study. Overall, 16% of participants who were infected at study entry and 40% of participants with newly acquired infections had molecular evidence of related infections with at least one injecting partner. Likely transmission clusters identified in phylogenetic analysis correlated with reported injecting relationships (adjusted Jaccard coefficient: 0.300; p<0.001). This is the first study to show that HCV phylogeny is associated with the injecting network, highlighting the importance of the injecting network in HCV transmission.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] Concordance between self-reported and actual hepatitis C virus infection status in a cohort of people who inject drugs
    O'Keefe, Daniel
    Aitken, Campbell
    Higgs, Peter
    Dietze, Paul
    DRUG AND ALCOHOL REVIEW, 2013, 32 (02) : 208 - 210
  • [22] Recommendations for the Management of Hepatitis C Virus Infection Among People Who Inject Drugs
    Robaeys, Geert
    Grebely, Jason
    Mauss, Stefan
    Bruggmann, Philip
    Moussalli, Joseph
    De Gottardi, Andrea
    Swan, Tracy
    Arain, Amber
    Kautz, Achim
    Stoever, Heino
    Wedemeyer, Heiner
    Schaefer, Martin
    Taylor, Lynn
    Backmund, Markus
    Dalgard, Olav
    Prins, Maria
    Dore, Gregory J.
    CLINICAL INFECTIOUS DISEASES, 2013, 57 : S129 - S137
  • [23] History of detention and the risk of hepatitis C among people who inject drugs in Germany
    Gassowski, Martyna
    Nielsen, Stine
    Bannert, Norbert
    Bock, Claus-Thomas
    Bremer, Viviane
    Ross, R. Stefan
    Wenz, Benjamin
    Marcus, Ulrich
    Zimmermann, Ruth
    Hecht, Andreas
    Heinz, Werner
    Klee, Juergen
    Leicht, Astrid
    Scherbaum, Norbert
    Schaeffer, Dirk
    Santos-Hoevener, Claudia
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2019, 81 : 100 - 106
  • [24] HIV-1 and hepatitis C virus selection bottleneck in Chinese people who inject drugs
    Li, Fan
    Ma, Liying
    Feng, Yi
    Ruan, Yuhua
    Hu, Jing
    Song, Hongshuo
    Liu, Pengtao
    Ma, Jun
    Rui, Baolin
    Kerpen, Kate
    Scheinfeld, Benjamin
    Srivastava, Tuhina
    Metzger, David
    Li, Hui
    Bar, Katharine J.
    Shao, Yiming
    AIDS, 2018, 32 (03) : 309 - 320
  • [25] Integrated models of care for people who inject drugs and live with hepatitis C virus: A systematic review
    Socias, M. Eugenia
    Karamouzian, Mohammad
    Parent, Stephanie
    Barletta, Jose
    Bird, Kathleen
    Ti, Lianping
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2019, 72 : 146 - 159
  • [26] Dynamic modelling of hepatitis C virus transmission among people who inject drugs: a methodological review
    Cousien, A.
    Tran, V. C.
    Deuffic-Burban, S.
    Jauffret-Roustide, M.
    Dhersin, J-S
    Yazdanpanah, Y.
    JOURNAL OF VIRAL HEPATITIS, 2015, 22 (03) : 213 - 229
  • [27] Short and sporadic injecting cessation episodes as predictors of incident hepatitis C virus infection: findings from a cohort study of people who inject drugs in Montreal, Canada
    Fortier, Emmanuel
    Artenie, Andreea Adelina
    Zang, Geng
    Utras-Aswad, Didier
    Roy, Elise
    Grebely, Jason
    Bruneau, Julie
    ADDICTION, 2019, 114 (08) : 1495 - 1503
  • [28] Drug network identification predicts injecting risk behavior among people who inject drugs on hepatitis C virus treatment in Tayside, Scotland
    Malaguti, Amy
    Byrne, Christopher J.
    Sani, Fabio
    Power, Kevin
    Eriksen, Ann
    Dillon, John F.
    BEHAVIORAL MEDICINE, 2024, 50 (02) : 130 - 140
  • [29] Opioid substitution therapy protects against hepatitis C virus acquisition in people who inject drugs: the HITS-c study
    White, Bethany
    Dore, Gregory J.
    Lloyd, Andrew R.
    Rawlinson, William D.
    Maher, Lisa
    MEDICAL JOURNAL OF AUSTRALIA, 2014, 201 (06) : 326 - 329
  • [30] Hepatitis C care continuum and associated barriers among people who inject drugs in Chennai, India
    Patel, Eshan U.
    Solomon, Sunil S.
    McFall, Allison M.
    Srikrishnan, Aylur K.
    Pradeep, Amrose
    Nandagopal, Paneerselvam
    Laeyendecker, Oliver
    Tobian, Aaron A. R.
    Thomas, David L.
    Sulkowski, Mark S.
    Kumar, M. Suresh
    Mehta, Shruti H.
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2018, 57 : 51 - 60